Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 07 09 2020
revised: 04 11 2020
accepted: 11 11 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 30 7 2021
Statut: epublish

Résumé

Transfer-RNA-derived fragments (tRFs) are a class of small non-coding RNAs that are functionally different from their parental transfer RNAs (tRNAs). tRFs can regulate gene expression by several mechanisms, and are involved in a variety of pathological processes. Here, we aimed at understanding the composition and abundance of tRFs in squamous cell carcinoma of the head and neck (SCCHN), and evaluated the potential of tRFs as prognostic markers in this cancer type. We obtained tRF expression data from The Cancer Genome Atlas (TCGA) HNSC cohort (523 patients) using MINTbase v2.0, and correlated to available TCGA clinical data. RNA-binding proteins were predicted according to the calculated Position Weight Matrix (PWM) score from the RNA-Binding Protein DataBase (RBPDB). A total of 10,158 tRFs were retrieved and a high diversity in expression levels was seen. Fifteen tRFs were found to be significantly associated with overall survival (Kaplan-Meier survival analysis, log rank test

Identifiants

pubmed: 33202812
pii: genes11111344
doi: 10.3390/genes11111344
pmc: PMC7698123
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
RNA-Binding Proteins 0
RNA, Transfer 9014-25-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cell. 2015 May 7;161(4):790-802
pubmed: 25957686
Cancer Res. 2019 Jun 15;79(12):3034-3049
pubmed: 30996049
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9810-5
pubmed: 27528663
Am J Cancer Res. 2020 Feb 01;10(2):393-402
pubmed: 32195016
RNA Biol. 2020 Aug;17(8):1214-1222
pubmed: 32116113
J Pathol Clin Res. 2019 Oct;5(4):240-247
pubmed: 31237113
Proc Natl Acad Sci U S A. 2016 May 3;113(18):5071-6
pubmed: 27071132
Cancer Res. 1977 Sep;37(9):3362-6
pubmed: 884680
Nucleic Acids Res. 2011 Jan;39(Database issue):D301-8
pubmed: 21036867
Genes Dev. 2020 Jan 1;34(1-2):118-131
pubmed: 31831626
Oncotarget. 2016 Apr 26;7(17):24766-77
pubmed: 27015120
Cancer Lett. 2019 Jun 28;452:31-37
pubmed: 30905816
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Head Neck. 2019 Oct;41 Suppl 1:19-45
pubmed: 31573749
Front Oncol. 2019 Sep 26;9:959
pubmed: 31616639
Science. 2016 Jan 22;351(6271):397-400
pubmed: 26721680
N Engl J Med. 2020 Jan 2;382(1):60-72
pubmed: 31893516
Cell Rep. 2018 Jan 2;22(1):286-298
pubmed: 29298429
Oncotarget. 2015 Aug 7;6(22):19246-63
pubmed: 26057471
Cancer Lett. 2018 Feb 1;414:16-25
pubmed: 29107107
EMBO Rep. 2019 Jul;20(7):e47789
pubmed: 31267708
Cell. 2009 Jul 23;138(2):215-9
pubmed: 19632169
Lancet Oncol. 2019 Jun;20(6):e313-e326
pubmed: 31162105
Nature. 2017 Dec 7;552(7683):57-62
pubmed: 29186115
Cancer Res. 2017 Jun 15;77(12):3194-3206
pubmed: 28446464
Nat Rev Cancer. 2018 May;18(5):269-282
pubmed: 29497144
Cell Cycle. 2010 Oct 15;9(20):4106-9
pubmed: 20948310
Curr Top Med Chem. 2018;18(3):214-218
pubmed: 29345578
JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):519-525
pubmed: 29801040
RNA. 2018 Aug;24(8):1093-1105
pubmed: 29844106
Oncotarget. 2015 Sep 22;6(28):24797-822
pubmed: 26325506
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18201-6
pubmed: 25404306
Mol Cell. 2011 Aug 19;43(4):613-23
pubmed: 21855800
Neural Regen Res. 2020 Feb;15(2):212-221
pubmed: 31552886
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8071-8076
pubmed: 28696308
BMC Med. 2012 May 29;10:51
pubmed: 22642691
Oncotarget. 2017 Mar 21;8(12):19389-19402
pubmed: 28038473
Signal Transduct Target Ther. 2020 Jun 30;5(1):109
pubmed: 32606362
RNA Biol. 2013 Apr;10(4):553-63
pubmed: 23563448
J Cell Biol. 2009 Apr 6;185(1):35-42
pubmed: 19332886
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3816-25
pubmed: 26124144
Bioinformatics. 2016 Aug 15;32(16):2481-9
pubmed: 27153631
Nucleic Acids Res. 2018 Jan 4;46(D1):D152-D159
pubmed: 29186503
RNA Biol. 2017 Oct 3;14(10):1364-1373
pubmed: 27892771
Cancer. 1979 Dec;44(6):2120-3
pubmed: 509391
RNA. 2010 Apr;16(4):673-95
pubmed: 20181738

Auteurs

Xiaolian Gu (X)

Department of Medical Biosciences/Pathology, Umeå University, 90185 Umeå, Sweden.

Lixiao Wang (L)

Department of Medical Biosciences/Pathology, Umeå University, 90185 Umeå, Sweden.

Philip J Coates (PJ)

Regional Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, 65653 Brno, Czech Republic.

Linda Boldrup (L)

Department of Medical Biosciences/Pathology, Umeå University, 90185 Umeå, Sweden.

Robin Fåhraeus (R)

Department of Medical Biosciences/Pathology, Umeå University, 90185 Umeå, Sweden.
Regional Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, 65653 Brno, Czech Republic.
Institute of Molecular Genetics, University Paris 7, St. Louis Hospital, 75010 Paris, France.

Torben Wilms (T)

Department of Clinical Sciences/ENT, Umeå University, 90185 Umeå, Sweden.

Nicola Sgaramella (N)

Department of Medical Biosciences/Pathology, Umeå University, 90185 Umeå, Sweden.

Karin Nylander (K)

Department of Medical Biosciences/Pathology, Umeå University, 90185 Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH